Aurobindo Pharma USA Inc recalls Dicyclomine Hydrochloride Capsules
- Published
- 12 Aug 2026
- Units affected
- 6,408 bottles distributed to market
- Agency
- FDA
- Country
- United States
The hazard
Shortfill; reports of empty capsules.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
- Brand / company
- Aurobindo Pharma USA Inc
- Codes / lots
- Batch # DMC125018A, Exp Date: 07/2027.
- Distribution
- US Nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 12 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.